Michael E. Wechsler, MD, a pulmonologist at National Jewish Health, discusses the conditions that can develop as a result of abnormal eosinophilic activity.
Michael E. Wechsler, MD, a pulmonologist at National Jewish Health, discusses the conditions that can develop as a result of abnormal eosinophilic activity.
Transcript
What are some of the challenges with distinguishing eosinophilic asthma from other diagnoses associated with abnormal eosinophils?
Well, you have to recognize that the eosinophils are involved and you can do that easily by evaluating the number of eosinophils in the blood. And so, with any disease state, you want to look for eosinophils in the blood or in the tissue. And there are major challenges in terms of distinguishing from other eosinophilic conditions, other than the fact that there can be some overlap between the different conditions. So, for instance, there's eosinophilic asthma, that's basically just airway disease with eosinophils in the blood and/or the airway, and then there's an entity called chronic eosinophilic pneumonia, which is basically eosinophilic asthma with some chronic sinus disease and pulmonary infiltrates. And then, there is an entity called EGPA, or eosinophilic granulomatosis with polyangiitis. And that's an entity that's characterized by asthma, eosinophilia, sinus disease, pulmonary infiltrates, and then vasculitis in 1 or more end organ including neuropathy. And lastly, there are hypereosinophilic syndromes, which aren't really associated to asthma but have eosinophilia and organ involvement in systemic manifestations.
Strategies for Improving Patient Access to Dermatology Care
March 22nd 2025Elizabeth Jones, MD, FAAD, highlights the persistent issue of insurance companies favoring expensive, newer medications over equally effective generics in dermatology, emphasizing the time-consuming prior authorization process and advocating for patient partnerships and systemic improvements.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Redefining Long COVID Care With Personalized Treatment
March 20th 2025To mark the 5-year anniversary of the COVID pandemic, The American Journal of Managed Care® spoke with Noah Greenspan, DPT, PT, CCS, EMT-B, cardiopulmonary physical therapist and director of the Pulmonary Wellness and Rehabilitation Center in New York City.
Read More
How Mirdametinib Improves QOL for People With NF1-Associated Plexiform Neurofibromas
March 18th 2025Christopher L. Moertel, MD, University of Minnesota, discusses the trial data that helped get mirdametinib approved and what providers can do to keep measuring quality of life (QOL) improvements.
Read More